The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.
Below is a clickable Heat Map of the 1 symbols on this page. The percent change is based on Friday's prices. Each symbol is a hyperlink or shortcut to more information.CELG 0.09%
Market Cap 79 Billion
Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.
EPS 2.38 P/E Ratio 17.70
Previous Tue, Jul 30, 2019
Latest Thu, Oct 24, 2019 (22 days ago) Price +4.70%
Pay Date --
CELG Charts52 Week High $110.70 on Wed, Nov 13, 2019.
Dec 26, 2018
Nov 13, 2019
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.